O'Reilly Insider Wilbanks: 88,485 Shares Sold; Options Granted Aug 13, 2025
Rhea-AI Filing Summary
C. David Wilbanks, Senior Vice President of Merchandise at O'Reilly Automotive, reported multiple transactions dated 08/13/2025 and signed 08/15/2025. The filing shows acquisitions of 13,485 and 75,000 non-derivative common shares (both marked with code M) at reported prices of $17.09 and $18.15 respectively, and a disposition of 88,485 common shares sold at $102.5376. Table II records two nonqualified employee stock options with exercise prices of $17.09 (13,485 options) and $18.15 (75,000 options); both are shown as acquired on 08/13/2025 with stated vesting that begins in four equal annual installments from the listed grant dates. The report shows 10,305 shares beneficially owned following the transactions.
Positive
- Option grants disclosed with specific exercise prices ($17.09 and $18.15) and vesting language, providing transparency into executive compensation
- Detailed transaction reporting shows quantities and prices, leaving clear post-transaction beneficial ownership (10,305 shares)
Negative
- Large sale of 88,485 shares at $102.5376 reduced insider-held shares materially
- Post-transaction beneficial ownership is relatively small (10,305 shares), which may limit insider alignment by shareholding alone
Insights
TL;DR: Routine insider option grants and a sizable share sale were reported; appears to be standard compensation and liquidity activity.
The Form 4 documents contemporaneous option acquisitions and a substantial sale of the same aggregate number of shares (88,485). The filing explicitly lists grant-level details including exercise prices and vesting commencement language stating the options vest in four equal annual installments beginning on the stated dates. The residual beneficial ownership after these transactions is 10,305 shares. This pattern—option grants consistent with employee compensation and concurrent sales—does not on its face indicate unusual corporate governance concerns within the limited facts disclosed.
TL;DR: Equity-based compensation activity recorded: two option grants and a large open-market sale; vesting schedule is disclosed.
The report shows two nonqualified stock option awards (13,485 at $17.09 and 75,000 at $18.15) acquired 08/13/2025 with exercisability and expiration dates noted in Table II. The explanatory note states vesting occurs in four equal annual installments from the listed dates. Separately, 88,485 common shares were sold at $102.5376, leaving the reporting person with 10,305 shares beneficially owned. For investors focused on dilution or executive compensation expense, the specific option sizes and exercise prices are material inputs but no company-wide financial impacts are provided in this Form 4.